Regulation of cyclin D2 and the cyclin D2 promoter by protein kinase A and CREB in lymphocytes

Oncogene. 2006 Apr 6;25(15):2170-80. doi: 10.1038/sj.onc.1209255.

Abstract

Lymphocyte proliferation is key to the regulation of the immune system. Cyclin D2 is the first cell cycle protein induced following stimulation through the T-cell receptor, the B-cell receptor or cytokines. The promoter of this cyclin integrates a diverse range of signals. Through investigating the regulation of this promoter by interleukin-2 and phosphatidylinositol 3-kinase, we have identified a role for the transcription factor CREB, cAMP response element-binding protein. Mutation of the CREB-binding site reduced cyclin D2 promoter activity 5-10-fold. CREB-1 is phosphorylated at serine 133, a critical site for activity, in both T cells and Epstein-Barr virus immortalized B cells. The introduction of an S133A mutant of CREB-1 reduces IL-2 induction of cyclin D2 promoter activity, demonstrating a role for this phosphorylation site in promoter activity. Two inhibitors of protein kinase A reduce lymphocyte proliferation and CREB-1 phosphorylation. This study demonstrates that the cyclin D2 promoter is capable of being regulated by PI3K and CREB and identifies CREB-1 and protein kinase A as potential targets for altering lymphocyte proliferation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • B-Lymphocytes / drug effects*
  • B-Lymphocytes / metabolism
  • B-Lymphocytes / virology
  • Blotting, Western
  • Carbazoles / pharmacology
  • Cell Proliferation / drug effects
  • Cell Transformation, Viral
  • Cells, Cultured
  • Cyclic AMP Response Element-Binding Protein / pharmacology*
  • Cyclic AMP-Dependent Protein Kinases / pharmacology*
  • Cyclin D2
  • Cyclins / genetics
  • Cyclins / metabolism*
  • Electrophoretic Mobility Shift Assay
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Indoles / pharmacology
  • Interleukin-2 / metabolism
  • Isoquinolines / pharmacology
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphorylation
  • Promoter Regions, Genetic*
  • Protein Kinase Inhibitors / pharmacology
  • Pyrroles / pharmacology
  • Sulfonamides / pharmacology
  • T-Lymphocytes / drug effects*
  • T-Lymphocytes / metabolism
  • Transcription, Genetic

Substances

  • CCND2 protein, human
  • Carbazoles
  • Cyclic AMP Response Element-Binding Protein
  • Cyclin D2
  • Cyclins
  • Enzyme Inhibitors
  • Indoles
  • Interleukin-2
  • Isoquinolines
  • Protein Kinase Inhibitors
  • Pyrroles
  • Sulfonamides
  • KT 5720
  • Phosphatidylinositol 3-Kinases
  • Cyclic AMP-Dependent Protein Kinases
  • N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide